APOL1 Proteomic Risk Score Predicts Kidney Disease Progression

Follow Drugslib on

By Elana Gotkine HealthDay Reporter

Medically reviewed by Carmen Pope, Senior Medical Editor, B. Pharm. Last updated on April 27, 2026.

via HealthDay

MONDAY, April 27, 2026 -- A nine-protein apolipoprotein L1 (APOL1) Proteomic Risk Score (APRS) enables accurate prediction of kidney disease progression in APOL1 high-risk individuals, according to a study published online April 15 in Nature Medicine.

Chenyu Li, Ph.D., from the University of Pennsylvania in Philadelphia, and colleagues profiled plasma proteomes of 851 Penn Medicine BioBank participants of African ancestry with APOL1 high-risk genotypes and preserved estimated glomerular filtration rate (eGFR). APRS, which predicts a composite outcome of ≥40 percent eGFR decline, kidney failure, or death, was derived using elastic net Cox regression adjusted for age, sex, eGFR, and albuminuria.

The researchers found that the time-dependent area under the receiver operating characteristic curve (tAUC) was 86.5 percent with APRS, outperforming the Kidney Failure Risk Equation (66.1 percent) and polygenic risk scores, which had 10-year event rates of 62.5 versus 3.3 percent across quintiles of risk. Robust accuracy was confirmed in external validation in the Atherosclerosis Risk in Communities and U.K. Biobank cohorts (tAUC, 82 to 85 percent); performance was consistent across demographic and clinical subgroups. There was a correlation for plasma levels of APRS component proteins with kidney tissue fibrosis and tubular injury pathways.

"One of the challenges in developing new therapies has been identifying the right patients early enough," senior author Katalin Susztak, M.D., Ph.D., also from the University of Pennsylvania, said in a statement. "This provides a way to focus treatment on those most likely to benefit."

Several authors disclosed ties to the biopharmaceutical industry.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2026-04-28 02:13

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords